Luwen Zhu

916 total citations · 2 hit papers
18 papers, 687 citations indexed

About

Luwen Zhu is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Luwen Zhu has authored 18 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 6 papers in Biomaterials and 5 papers in Molecular Biology. Recurrent topics in Luwen Zhu's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Ferroptosis and cancer prognosis (3 papers). Luwen Zhu is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Ferroptosis and cancer prognosis (3 papers). Luwen Zhu collaborates with scholars based in China and Australia. Luwen Zhu's co-authors include Yongzhong Du, Xiaoling Xu, Yuchan You, Jucong Zhang, Jiansong Ji, Yanling Song, Jiahao Hu, Yan Du, Di Liu and Minxia Zhu and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Luwen Zhu

16 papers receiving 683 citations

Hit Papers

Adipose‐Derived Mesenchymal Stem Cell‐Derived Exosomes Bi... 2023 2026 2024 2025 2023 2025 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luwen Zhu China 12 283 274 161 103 92 18 687
Yuchan You China 14 433 1.5× 316 1.2× 216 1.3× 166 1.6× 142 1.5× 21 897
Shobha Regmi South Korea 20 198 0.7× 314 1.1× 228 1.4× 44 0.4× 49 0.5× 37 963
Zhengang Zha China 20 209 0.7× 341 1.2× 204 1.3× 29 0.3× 38 0.4× 45 968
Ziming Yuan China 17 180 0.6× 336 1.2× 270 1.7× 91 0.9× 74 0.8× 38 883
Lin Weng China 14 194 0.7× 233 0.9× 124 0.8× 73 0.7× 17 0.2× 23 685
Hee Su Sohn South Korea 11 407 1.4× 342 1.2× 167 1.0× 39 0.4× 235 2.6× 15 967
Youngmi Ji United States 14 108 0.4× 273 1.0× 50 0.3× 54 0.5× 80 0.9× 24 640

Countries citing papers authored by Luwen Zhu

Since Specialization
Citations

This map shows the geographic impact of Luwen Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luwen Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luwen Zhu more than expected).

Fields of papers citing papers by Luwen Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luwen Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luwen Zhu. The network helps show where Luwen Zhu may publish in the future.

Co-authorship network of co-authors of Luwen Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Luwen Zhu. A scholar is included among the top collaborators of Luwen Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luwen Zhu. Luwen Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Jucong, Luwen Zhu, Jiahao Hu, et al.. (2025). Injectable Glycosaminoglycan Hydrogel with Immunosuppressive Exosomes for Macrophage Polarization and Cartilage Repair in a Rheumatoid Arthritis Treatment. ACS Applied Materials & Interfaces. 17(45). 61784–61798.
2.
Zhu, Luwen, Jiahao Hu, Xiaochuan Wu, et al.. (2025). Programmed enhancement of endogenous iron-mediated lysosomal membrane permeabilization for tumor ferroptosis/pyroptosis dual-induction. Nature Communications. 16(1). 3017–3017. 16 indexed citations breakdown →
3.
Zhang, Yutao, et al.. (2025). Recent Advances in Nanomedicine for Modulating Intratumoral Bacteria in Cancer Therapy. Molecular Pharmaceutics. 22(10). 5767–5790. 1 indexed citations
4.
Zhu, Luwen & Yongzhong Du. (2024). A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron. International Journal of Pharmaceutics. 662. 124517–124517. 5 indexed citations
5.
You, Yuchan, Luwen Zhu, Yanling Song, et al.. (2024). Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer Therapy. ACS Nano. 18(26). 17119–17134.
6.
Zhu, Qi, Jucong Zhang, Yanling Song, et al.. (2024). Hybrid hair follicle stem cell extracellular vesicles co-delivering finasteride and gold nanoparticles for androgenetic alopecia treatment. Journal of Controlled Release. 373. 652–666. 23 indexed citations
7.
Song, Yanling, Yuchan You, Xinyi Xu, et al.. (2023). Adipose‐Derived Mesenchymal Stem Cell‐Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration. Advanced Science. 10(30). e2304023–e2304023. 153 indexed citations breakdown →
8.
You, Yuchan, Feiyang Jin, Luwen Zhu, et al.. (2023). A photo-activable nano-agonist for the two-signal model of T cell in vivo activation. Journal of Controlled Release. 361. 681–693. 3 indexed citations
9.
Liu, Di, Yanling Song, Hui Chen, et al.. (2023). Anti-VEGFR2 F(ab′)2 drug conjugate promotes renal accumulation and glomerular repair in diabetic nephropathy. Nature Communications. 14(1). 8268–8268. 7 indexed citations
10.
Hu, Jiahao, Yuchan You, Luwen Zhu, et al.. (2023). Sialic Acid‐Functionalized Pyroptosis Nanotuner for Epigenetic Regulation and Enhanced Cancer Immunotherapy. Small. 20(10). e2306905–e2306905. 12 indexed citations
11.
Zhu, Minxia, Luwen Zhu, Yuchan You, et al.. (2023). Positive Chemotaxis of CREKA-Modified Ceria@Polydopamine Biomimetic Nanoswimmers for Enhanced Penetration and Chemo-photothermal Tumor Therapy. ACS Nano. 17(17). 17285–17298. 16 indexed citations
12.
Zhu, Luwen, Yuchan You, Minxia Zhu, et al.. (2022). Ferritin‐Hijacking Nanoparticles Spatiotemporally Directing Endogenous Ferroptosis for Synergistic Anticancer Therapy. Advanced Materials. 34(51). e2207174–e2207174. 98 indexed citations
13.
Shan, Chunlei, Yuchan You, Minjiang Chen, et al.. (2022). NIR-II fluorescence imaging-guided hepatocellular carcinoma treatment via IR-1061-acridine and lenvatinib co-loaded thermal-sensitive micelles and anti-PD-1 combinational therapy. Chemical Engineering Journal. 454. 140437–140437. 13 indexed citations
14.
Wang, Jun, Jing Qi, Feiyang Jin, et al.. (2021). Spatiotemporally light controlled “drug-free” macromolecules via upconversion-nanoparticle for precise tumor therapy. Nano Today. 42. 101360–101360. 16 indexed citations
15.
Qi, Jing, Feiyang Jin, Yuchan You, et al.. (2021). Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles. Nature Communications. 12(1). 4755–4755. 122 indexed citations
16.
Sun, Mingchen, Xiaoling Xu, Yan Du, et al.. (2021). Biomimetic Melanosomes Promote Orientation-Selective Delivery and Melanocyte Pigmentation in the H2O2-Induced Vitiligo Mouse Model. ACS Nano. 15(11). 17361–17374. 26 indexed citations
17.
Liu, Di, Mingchen Sun, Gaofeng Shu, et al.. (2021). Multifunctional Gd-CuS loaded UCST polymeric micelles for MR/PA imaging-guided chemo-photothermal tumor treatment. Nano Research. 15(3). 2288–2299. 15 indexed citations
18.
Liu, Di, Gaofeng Shu, Feiyang Jin, et al.. (2020). ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule. Science Advances. 6(41). 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026